Fig. 5.
Percentage of islet donors causing high cytotoxic T lymphocyte precursor assay (CTLp) reactivity in the first 26 weeks after islet transplantation, stratified for patients who were (n = 15) or were not (n = 15) insulin-independent after 26 weeks. Filled circles depict patients transplanted under tacrolimus–mycophenolate mofetil (TAC–MMF) immunosuppression, open circles patients transplanted under TAC–sirolimus (SIR) and grey circles patients under SIR only. P-value TAC–MMF: P = 0·35, non-TAC–MMF: P = 0·03.